Arlington Trust’s Globus Medical GMED Stock Holding History

Arlington Trust’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1K	Hold	140	–	–	﹤0.01%	452
2026 Q1	$12.1K	Buy	+140	New	+$12.6K	﹤0.01%	407

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Arlington Trust's GMED Position: Q2 2026 in Review

Arlington Trust held its Globus Medical (GMED) position steady in Q2 2026 at 140 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Arlington Trust first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. The position peaked at $12.1K in Q1 2026. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Arlington Trust held 140 shares of Globus Medical worth $11.1K as of Q2 2026.
Arlington Trust left its Globus Medical share count unchanged in Q2 2026.
Globus Medical made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #452 holding.
Arlington Trust first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
Arlington Trust's Globus Medical position peaked at $12.1K in Q1 2026.
597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.